Form 4 Tracker
LIGAND PHARMACEUTICALS INC
LGND

30 insider filings · Latest: Jun 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Dec 1, 2025Dec 1 9:08 PMKOZARICH JOHN W
Proposed Sale
467$199.88$93.3K

View →

Nov 7, 2025Nov 7 10:05 PMNANCY GRAY
Proposed Sale
6,571$205.45$1.4M

View →

Nov 7, 2025Nov 7 9:05 PMJOHN L LAMATTINA
Proposed Sale
4,179$205.45$858.6K

View →

Nov 3, 2025Nov 3 9:05 PMKOZARICH JOHN W
Proposed Sale
467$191.05$89.2K

View →

Oct 1, 2025Oct 1 8:09 PMKOZARICH JOHN W
Proposed Sale
467$176.68$82.5K

View →

Sep 23, 2025Sep 23 8:50 PMJASON M ARYEH
Proposed Sale
10,000$170.81$1.7M

View →

Sep 17, 2025Sep 17 4:41 PMAryeh Jason
Proposed Sale
10,000$168.50$1.7M

View →

Sep 2, 2025Sep 2 8:16 PMKOZARICH JOHN W
Proposed Sale
467$161.71$75.5K

View →

Aug 1, 2025Aug 1 8:04 PMKOZARICH JOHN W
Proposed Sale
467$131.00$61.2K

View →

Jul 10, 2025Jul 10 9:08 PMKOZARICH JOHN W
Proposed Sale
934$125.00$116.8K

View →

Jun 23, 2025Jun 23 9:07 PMANDREW THOMAS REARDON
Proposed Sale
500$114.08$57.0K

View →

Jun 10, 2025Jun 10 10:49 PMANDREW THOMAS REARDON
Proposed Sale
500$114.54$57.3K

View →

May 15, 2025May 15 9:14 PMANDREW THOMAS REARDON
Proposed Sale
1,000$104.00$104.0K

View →

Mar 18, 2025Mar 18 8:01 PMSabba Stephen L
Proposed Sale
2,406$106.00$255.0K

View →

Mar 4, 2025Mar 4 10:10 PMEspinoza Octavio
Proposed Sale
5,000$115.03$575.1K

View →

Dec 23, 2024Dec 24 1:19 AMEspinoza Octavio
Proposed Sale
2,104$116.37$244.9K

View →

Nov 26, 2024Nov 27 9:44 PMLAMATTINA JOHN L
Proposed Sale
2,406$119.19$286.8K

View →

Sep 23, 2024Sep 23 9:30 PMReardon Andrew
Proposed Sale
2,000$99.60$199.2K

View →

Sep 23, 2024Sep 23 9:27 PMKorenberg Matthew E
Proposed Sale
14,437$101.50$1.5M

View →

Sep 20, 2024Sep 20 10:12 PMKorenberg Matthew E
Proposed Sale
6,275$104.10$653.2K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 4, 2026Mar 6 11:51 PMAndrew ReardonCLO & Secretary
Option Exercise
5,000$52.2754,444(D)

View →

Mar 4, 2026Mar 6 11:49 PMOctavio EspinozaChief Financial Officer
Option Exercise
2,073$80.720(D)

View →

Mar 3, 2026Mar 5 4:05 PMStephen L SabbaDirector
Option Exercise
2,034$69.510(D)

View →

← Previous

Page 2 of 2